AASLD The Liver Meeting 2019
Boston, USA | November 8-12
Visit Booth #511 and Check Out Oral and Poster Presentations
PhoenixBio would be pleased to welcome you at the exhibition booth #511 at The Liver Meeting® 2019. The Meeting is hosting plenary sessions, and features a three-day exhibition from Saturday to Monday, November 9 to 11, 2019.
Find more details at: https://www.aasld.org/event/liver-meeting?PF=1
Featured NASH poster #2219
“Development of A Humanized NASH Model with A Fructose-Containing High Fat, High Cholesterol Diet Using Humanized Liver Chimeric Mice”
Presenter: Keishi Kisoh, Ph.D. (PhoenixBio Co., Ltd.)
Date & time: Monday, November 11, 2019, 12:30 – 1:30 PM
Learn more about the PXB-Mouse® and PXB-cells®:
Oral Presentation
# 275: Understanding Early HBV Kinetics During Infection and Treatment in Primary Human Hepatocytes: A Data-Driven Mathematical Modeling Approach
Presenter: Preeti Dubey, Ph.D. (Loyola University Medical Center)
Location: Hynes Convention Center, Hall B
Poster Presentations
Location: Hynes Convention Center, Hall B
Poster # 694: Dual Agonist of Farnesoid X Receptor and G Protein-Coupled Receptor TGR5 Inhibits Hepatitis B Virus Infection
Presenter: Kiyoaki Ito, Ph.D. (Aichi Medical University)
Poster # 1014: Permission of Hepatitis B Virus Infection in Jak3korag2ko Mouse
Presenter: Yuji Teraoka, Ph.D. (Hiroshima University)
Poster # 1025: Molecular Signature of Hepatitis B Virus Regulation By Interferon-Gamma In Primary Human Hepatocyte
Presenter: Takuto Nosaka (Second Department of Internal Medicine, University of Fukui)
Poster # 1030: Potential Role of Unfolded Protein Responses in IFN-Mediated Liver Injury During HBV Infection
Presenter: Ian Baudi, Ph.D. (Nagoya City University)
Poster # 1464: The Promising Therapeutic Effect of Recombinant Human Cytoglobin Against Mouse Liver Fibrosis And Stellate Cell Activation Via Ros Scavenger Function
Presenter: Ninh Quoc Dat (Department of Hepatology, Osaka City University Graduate School of Medicine)
Poster # 1639: Preclinical Development of a First-In-Class Fusion Inhibitor Against Diverse and Multidrug-Resistant HCV Strains
Presenter: Christopher Ma, Ph.D. (National Institute of Diabetes and Digestive and Kidney Diseases)
Poster # 1643: Resistance Analysis for Glecaprevir and Pibrentasvir On Genotype 1b Hepatitis C Virus Infection in Subgenomic Replicon Systems and Human Hepatocyte Transplanted Mice
Presenter: Mitsutaka Osawa, Ph.D. (Hiroshima University)
Poster # 2219: Development of A Humanized Non-Alcoholic Steatohepatitis Model with A Fructose-Containing High Fat, High Cholesterol Diet Using Humanized Liver Chimeric Mice
Presenter: Keishi Kisoh, Ph.D. (PhoenixBio Co., Ltd.)
Poster # 2261: A CBP/Beta-Catenin Signaling Inhibitor, PRI-724, Improves NASH-Induced Liver Fibrosis and Disorder
Presenter: Kenzaburo Yamaji, Ph.D. (Tokyo Metropolitan Institute of Medical Science)
Please feel free to stop by our booth if you are attending the conference to learn more about the PXB-Mouse®, the most widely used chimeric mouse with humanized liver, and PXB-cells®, fresh human hepatocytes isolated from PXB-Mouse®. If you are not attending AASLD 2019, please reach out for more information about our products (PXB-Mouse® and PXB-cells®) and services.